Incidence of Haemophilus influenzae type b meningitis among children less than 5 years of age in Slovakia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 6, 1999, Pages 409-413

  Novakova E ^a   Olear V ^a   Gessner, B D ^b  

^a Natl Haemophilus Ref Laboratory   (Slovakia)

^b Assoc Pour l'Aide a la Med Prev   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; BACTERIAL MENINGITIS; BACTERIUM CULTURE; CLINICAL ARTICLE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNIZATION; INFANT; MORBIDITY; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SERODIAGNOSIS; SLOVAKIA;

EID: 0032735694     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050309     Document Type: Article

References (20)

1. 1. McIntyre PB, Chey T, Smith WT: The impact of vaccination against invasive Haemophilus influenzae type b disease in the Sydney region. Medical Journal of Australia (1995) 162:245-248
2. 2. Urwin G, Yuan MF, Feldman RA: Prospective study of bacterial meningitis in northeast Thames region, 1991-3, during introduction of Haemophilus influenzae vaccine. British Medical Journal (1994) 309:1412-1414
3. 3. Singleton RJ, Davidson NM, Desmet IJ, Berner JE, Wainwright RB, Bulkow LR, Lilly CM, Siber GR: Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization. Pediatric Infectious Disease Journal (1994) 13:362-367
4. 4. Murphy TV, White KE, Pastor P, Gabriel L, Medley F, Granoff DM, Osterholm MT: Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. Journal of the American Medical Association (1993) 269:246-248
5. 5. World Health Organization: Generic protocol for population-based surveillance of Haemophilus influenzae type B. Global Programme for Vaccines and Immunization, Vaccine Research and Development. WHO, Geneva (1996)
6. 6. Fogarty J, Moloney AC, Newell JB: The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland. Epidemiology and Infection (1995) 114:451-463
7. 7. Fallon RJ, Reid D: Haemophilus influenzae type b invasive disease. British Medical Journal (1991) 303:1203-1204
8. 8. Claesson BA: Epidemiology of invasive Haemophilus influenzae type b disease in Scandinavia. Vaccine (1993) 11, Supplement 1:30-33
9. 9. Hugosson S, Silfverdal SA, Garpenholt O, Esbjorner E, Lindquist B, Vikerfors T, Werner B, Olcen P: Invasive Haemophilus influenzae disease: epidemiology and clinical spectrum before large-scale H. influenzae type b vaccination. Scandinavian Journal of Infectious Diseases (1995) 27:63-67
10. 10. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, Wenger JD: Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. Journal of The American Medical Association (1993) 269:221-226
11. 11. Hussey GD, Lasser ML, Reekie WD: The costs and benefits of a vaccination programme for Haemophilus influenzae type B disease. South African Medical Journal (1995) 85:20-25
12. 12. Trollfors B: Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden. Scandinavian Journal of Infectious Diseases (1994) 26:611-614
13. 13. Ginsberg GM, Kassis I, Dagan R: Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel. Journal of Epidemiology and Community Health (1993) 47:485-490
14. 14. Harris A, Hendrie D, Bower C, Payne J, de Klerk N, Stanley F: The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP. Medical Journal of Australia (1994) 160:483-488
15. 15. Levine OS, Ortiz E, Contreras R, Lagos R, Vial P, Misraji A, Ferreccio C, Espinoza C, Adlerstein L, Herrera P: Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile. American Journal of Epidemiology (1993) 137:1221-1228
16. 16. Gellert GA, Wenger JD, Brilla A: Haemophilus influenzae type b disease in Latvia. Lancet (1994) 344:959
17. 17. Feigin RD: Bacterial meningitis beyond the neonatal period. In: Feigin RD, Cherry JD (eds): Textbook of pediatric infectious diseases. W.B. Saunders, Philadelphia (1981) pp 293-308
18. 18. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, Weber M, Palmer A, Schneider G, Jobe K, Lahai G, Jaffar S, Secka O, Lin K, Ethevenaux C, Greenwood B: Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet (1997) 349:1191-1197
19. 19. Leach A, Twumasi PA, Kumah S, Banya WS, Jaffar S, Forrest BD, Granoff DM, LiButti DE, Carlone GM, Pais LB, Broome CV, Greenwood BM: Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. Journal of Infectious Diseases (1997) 175:200-204
20. 20. Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K: Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. Journal of Infectious Diseases (1996) 174:1360-1363